Comparative analysis of efficacy of certain neuroprotectors in ischemic stroke
Skorokhodov AP, Dudina AA, Kolesnikova EA, Koron AE, Kobantsev IuA, Sedova AA · 2006 · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · PMID 18193579
What does this source report?
Authors described broadly similar clinical effects in moderate ischemic stroke and some practical advantages for Cortexin.
- Population and setting
- Two comparative series: 35 patients in a Cortexin–Nootropil comparison and 45 in a Cortexin–Cerebrolysin comparison
- Evidence type
- Human comparative study
- Preparation
- See the original report; formulation details require verification.
- Source language
- English
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Allocation, masking and usable between-group effect estimates are unclear.
- This is not a reliable head-to-head ranking or proof of equivalence.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Review depth: Abstract reviewed
Source access and review scope
Indexed citation and abstract reviewed via Europe PMC / PubMed; full methods and risk of bias not comprehensively appraised.
Recorded source-check date: 2026-10-05. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Skorokhodov AP, Dudina AA, Kolesnikova EA, Koron AE, Kobantsev IuA, Sedova AA. Comparative analysis of efficacy of certain neuroprotectors in ischemic stroke Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · PMID 18193579 2006.
Molekul research summary: https://molekul.io/research/stroke-18193579. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entryRelated compound profiles
Cortexin
A tissue-derived preparation with Russian stroke, cognitive, pediatric and other clinical reports. Study designs vary; the independent stroke review is shown alongside favorable original reports. None validates the personal WHOOP diary.
Piracetam
Piracetam, marketed as Nootropil, connects the original nootropic concept with Soviet clinical adoption and later operator, hypoxia and maritime research. Healthy-volunteer experiments, clinical reviews and combination proposals answer different questions.
Cerebrolysin
Porcine brain-derived peptide mixture studied in neurological disease, rehabilitation and laboratory models. Clinical results, composition analyses and unresolved archival leads are separated in this collection.